Cargando…
SH2B1 promotes NSCLC cell proliferation through PI3K/Akt/mTOR signaling cascade
BACKGROUND: Non-small cell lung cancer (NSCLC), the most prevalent type of human lung cancer, is characterized by many molecular abnormalities. SH2B1, a member of the SH2-domain containing family, have recently been shown to act as tumor activators in multiple cancers. The objective of this study wa...
Autores principales: | Wang, Shaoqiang, Zheng, Yingying, He, Zhiwei, Zhou, Wolong, Cheng, Yuanda, Zhang, Chunfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127928/ https://www.ncbi.nlm.nih.gov/pubmed/30202243 http://dx.doi.org/10.1186/s12935-018-0632-x |
Ejemplares similares
-
MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC
por: Chen, Wei, et al.
Publicado: (2016) -
SH2B1 promotes epithelial‐mesenchymal transition through the IRS1/β‐catenin signaling axis in lung adenocarcinoma
por: Wang, Shaoqiang, et al.
Publicado: (2018) -
Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT
por: Zhang, Renjie, et al.
Publicado: (2020) -
YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
por: Xu, Wei, et al.
Publicado: (2021) -
The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells
por: Li, Chuntuan, et al.
Publicado: (2015)